A COVID-19 vaccine jointly developed by US pharmaceutical company Pfizer and Germany’s BioNTech is expected to get approval from the US Food and Drug Administration as soon as this week. In summer, the Trump administration struck a deal with the vaccine’s producers for the delivery of enough doses to immunise about 50 million Americans.
